Nov. 13-16 _ DP World Tour Championship, Dubai, United Arab Emirates ...

Amgen is a biotechnology leader with competitive advantages in scale, R&D, manufacturing efficiency, and distribution, bolstered by a robust pipeline and rising margins. I currently rate Amgen as ...

Less than a decade since it secured its first FDA approval for a biosimilar, Amgen’s portfolio of the copycat drugs is growing and making strong contributions to the company’s top line.

Amgen Inc.'s (NASDAQ:AMGN) dividend will be increasing from last year's payment of the same period to $2.38 on 7th of March. This takes the annual payment to 3.1% of the current stock price, which ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The company’s shares closed yesterday at $289.02.

My name is Julianne, and I will be your conference facilitator today for Amgen's fourth quarter and full year 2024 financial results conference call. All lines have been placed on mute to prevent ...

At any point in music time, there is space for a floppy-haired, fresh-faced, four-piece guitar band in the bloom of its youth ...

FASHION fans are set for a huge boost as a major store is set to open in Cork for the first time ... 550 UK stores after the pandemic hit, with Irish stores also impacted. Stores closed included ...

If the LIV Golf League were around when Rory McIlroy entered the professional game in 2007, he might have forgone the traditional DP World Tour and PGA Tour route for the upstart league.

Tiger Woods will compete in his first PGA Tour event for seven months next week at the Genesis Invitational in San Diego.

CROWN POINT, Ind. — An Ireland native made it her mission to bring the isle to Crown Point Saturday and Sunday for “The Irish Experience.” Aishling Wigmore wanted to bring more culture of ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...